Randomized Phase 3 Study of Panitumumab With FOLFIRI vs. FOLFIRI Alone as Second-Line Treatment in Patients With Metastatic Colorectal Cancer

作者： Gansert J , André T , Peeters M , Rong A , Chan E

DOI:

关键词: Internal medicine 、 Phases of clinical research 、 Second line treatment 、 Oncology 、 Colorectal cancer 、 Panitumumab 、 FOLFIRI 、 In patient 、 Medicine 、 Text mining